Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ivera Medical gains licence to BD IV technology

This article was originally published in Clinica

Executive Summary

Medical device manufacturer Ivera Medical has secured exclusive worldwide rights to patents covering intravenous port protector technology belonging to BD (Becton Dickinson). Ivera has gained a licence for issued and pending patents covering technology designed to reduce the potential for healthcare-acquired bloodstream infections. Ivera vice-president of marketing and sales Jack Saladow said that this deal would broaden the San Diego, California company’s existing patent applications and remove any potential patent issues between the two firms. No financial details of the deal were disclosed. Healthcare-acquired bloodstream infections are said to cost the US healthcare system more than $5bn each year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042507

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel